Trials / Terminated
TerminatedNCT00553709
Study of Nicotine for the Prevention of PONV
The Role of Transcutaneous Nicotine in the Prevention of Postoperative Nausea and Vomiting in Non-smokers
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- University Hospital, Geneva · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether nicotine is effective in the prevention of nausea and vomiting in non-smokers undergoing surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicotine | Nicotinell® Patch 10 cm2, containing 17.5 mg of nicotine, with an average delivery rate of 7 mg of nicotine per 24 hours (= TTS 10) |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2007-11-05
- Last updated
- 2009-09-29
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00553709. Inclusion in this directory is not an endorsement.